This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.
Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. Moving forward into 2020 many crops would have to be destroyed that have otherwise been able to be used for extraction for the last several years.
Using the data collected, ACS Laboratory extracted the strictest requirements per category to create the National Hemp Testing Panel and corresponding Certificate of Analysis. With that research, they created elaborate matrices to compare each mandate.
The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). VANCOUVER, BC , Dec. 13, 2021 /CNW/ – Havn Life Sciences Inc. (CSE: Chief Executive Officer.
Portland, OR — The Oregon Liquor Control Commission’s compliance and enforcement team was instrumental in the dismantling of an illegal marijuana processing site by local, state and federal law enforcement last week in rural Lane County. Also seized were items relating to the manufacture and sale of counterfeit vape cartridges.
The University of California, Davis (“UC Davis”), through an accepted research sponsorship from BRC, will lead the extraction and analysis of DNA to elucidate genetic variants taken from various genetic lines of Cannabis sativa. The UC Davis scientists will also test new approaches to extract RNA from dried material.
Although many producers convert plant-derived CBD into Delta-8 THC using a chemical process called isomerization, the hemp that is used to extract the CBD falls under the Farm Bill exemption. The Nevada Cannabis Compliance Board recently stated , “products exceeding 0.3% But not all states are in agreement.
The CAOA transfers regulation of cannabis from the Drug Enforcement Agency (DEA) to the FDA, the TTB and the Bureau of Alcohol, Tobacco, Firearms & Explosives (ATF) within the Department of Justice—giving the agencies similar regulatory and enforcement authority as they have with alcohol and tobacco. percent on a dry weight basis.”.
Delta-8 is derived from CBD extracted from hemp, but in scientific terms it is delta-8 THC. Many states are now scrambling to close legal loopholes in their drug laws to bring delta-8 into regulatory compliance. Anecdotally, we understand that the DEA is actively monitoring the proliferation of delta-8 THC products.”.
Federal law requires that taxpayers must report income from illegal sources – including cannabis sales (whether state sanctioned or not) – raising numerous tax compliance and design issues. The lawful cannabis industry faces numerous regulatory hurdles that makes even good-faith compliance with the law a challenge. Introduction.
percent Delta-9 THC, and that this “seemingly extends to downstream products and substances, so long as their delta-9 THC concentration does not exceed the statutory threshold” and are a derivative or extract of hemp. Thompson Hine LLP is available to assist vapor businesses with their compliance needs. FOR MORE INFORMATION.
The practical impact of this law is its clarification and affirmation that raw hemp – as well as cannabinoids, extracts and derivatives therefrom – is to be treated as an agricultural commodity, not a drug. Department of Agriculture (USDA), not the Drug Enforcement Agency (DEA). He can be reached at darren.kaplan@hoban.law.
Cannabis businesses that are ill-prepared for these regulatory requirements risk facing litigation, enforcement actions, fines or penalties, and negative publicity, while those taking a proactive approach to compliance may find opportunities to mitigate and even monetize those risks.
Department of Justice Drug Enforcement Administration (DEA) suggesting that cannabinoids synthetically produced from non-cannabis materials, including delta-8 THC, are controlled under the federal Controlled Substances Act as a “tetrahydrocannabinol.” Grassroots Federal/State Legislative Highlights.
Five of them used an age verification form , which is in compliance with the FDA age requirements and state laws, where the customer has to upload a photo of a government ID, and the other required a signature on delivery of the package. Those cannabinoids are easier to extract so there’s less risk with doing it wrong.
Concrete extraction technicians, researchers, marijuana cultivators, marketers, marijuana processors, cannabis branding, and developers will all have a place in the industry. Your business plan should address key considerations such as funding, marketing, competition, legal compliance, and other essential components of running your business.
A user located in Los Angeles could see listings for around 100 area storefronts, and ads for “deals nearby” on cannabis flower, extract, edibles, and other products. Even then, publishers should require that any cannabis-business certify its compliance with state and local laws. any other Federal criminal statute.”
Recreational B2B net sales in Q4 2021 increased 40% over prior year period due primarily to growth in the retail store network in Canada over the fiscal year and growth in value flower and sales of ingestible cannabis, cannabis extracts and cannabis topical products. Drug Enforcement Administration (the “DEA”), the U.S.
11,12 CBD, the non-psychoactive cannabinoid, is extracted from the flower of industrial hemp. 5,16 Tinctures are liquid, ultra-concentrated alcohol-based cannabis extracts commonly applied in and absorbed through the mouth. Cannabis sativa with less than 0.3% 13 Marijuana and hemp, technically speaking, are the same plant.
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.
On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. Emphasis added).
The seeds themselves have little to no THC, regardless of whether they were extracted from or may germinate into a plant that has more than 0.3% CBP is the federal agency responsible for ensuring that imported goods are allowed to enter only if they are in compliance with all applicable U.S. laws and regulations. federal law.
Because Delta-8 THC is not expressed in sufficient concentrations in most hemp strains to make its extraction financially viable, most Delta-8 THC on the market is derived from the chemical conversion of hemp-derived cannabidiol (“CBD”). This chemical conversion is at the root of the legal confusion.
Noncompliant hemp used to require its disposal or remediation be conducted by a government official from an agency like the DEA. Hemp must be tested at DEA-registered laboratories, as previous rules state. Verghese said next steps need to include addressing extraction and manufacturing of finished goods. View original article.
In accordance with state law, all CannaMD doctors hold an active, unrestricted license as either an allopathic physician or osteopathic physician and are in compliance with all state-mandated education requirements. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening.
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. Emphasis added). State-compliant cannabis activity would no longer violate federal criminal law.
Drug Enforcement Agency (DEA)’s narcotic drug schedule as defined by the Controlled Substances Act (CSA). If an online CBD company needs assistance with payment processing, some banks may require that they sign a compliance agreement. Cannabidiol (CBD) products derived from industrial hemp exist in a unique market here in the U.S.
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. The 2018 Farm Bill also defines hemp to include all derivatives, extracts, and cannabinoids of hemp. Challenging the DEA hemp rule. What’s the issue then?
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. The 2018 Farm Bill also defines hemp to include all derivatives, extracts, and cannabinoids of hemp. Challenging the DEA hemp rule. What’s the issue then?
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content